ClinicalTrials.Veeva
Menu

Find clinical trials for Ovarian Cancer in Philadelphia, PA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Ovarian Epithelial Carcinoma
Cancer
Carcinoma
Endometrial Cancer
Fallopian Tube Cancer
Breast Cancer
Triple Negative Breast Cancer

Ovarian Cancer trials near Philadelphia, PA, USA:

Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer

the study drugs fostamatinib and paclitaxel. This study tests different doses of the drugs to see which doses are safest in people with ovaria cancer...

Active, not recruiting
Ovarian Cancer
Drug: Fostamatinib and Paclitaxel

Phase 1

Johns Hopkins Medicine
Johns Hopkins Medicine

Philadelphia, Pennsylvania, United States and 2 other locations

The goal of this clinical trial is to compare participants with ovarian, fallopian tube or primary peritoneal cancer when treated w...

Active, not recruiting
Ovarian Neoplasms
Ovarian Cancer
Biological: Vigil
Other: Placebo

Phase 2

Gradalis

Philadelphia, Pennsylvania, United States of America and 25 other locations

This study is testing whether a 6 week skills-based telehealth intervention can help ovarian cancer patients experiencing PARP inhi...

Active, not recruiting
Ovarian Cancer
Coping Skills
Behavioral: REVITALIZE ACT Intervention
Behavioral: Enhanced Usual Care (EOC)
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Philadelphia, Pennsylvania, United States and 1 other location

followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...

Active, not recruiting
Advanced Ovarian Cancer
Drug: Durvalumab placebo
Drug: Bevacizumab

Phase 3

AstraZeneca
AstraZeneca

Philadelphia, Pennsylvania, United States and 213 other locations

be tested together for the first time in patients with recurrent ovarian, fallopian tube, or peritoneal cancer to determine the saf...

Active, not recruiting
Recurrent Epithelial Ovarian Cancer
Recurrent Peritoneal Cancer
Drug: Epacadostat (INCB024360)
Drug: Cyclophosphamide

Phase 1, Phase 2

Immunovaccine

Philadelphia, Pennsylvania, United States and 8 other locations

and potential activity of a single intravenous (IV) dose of SynKIR-110 administered to subjects with mesothelin-expressing advanced ovarian ...

Enrolling
Ovarian Cancer
Cholangiocarcinoma Recurrent
Biological: SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR

Phase 1

Verismo Therapeutics

Philadelphia, Pennsylvania, United States and 2 other locations

positive, recurrent platinum sensitive, high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancer following 1 pri...

Active, not recruiting
Primary Peritoneal Cancer
High Grade Ovarian Cancer
Drug: Mirvetuximab soravtansine
Drug: Carboplatin

Phase 2

ImmunoGen
ImmunoGen

Camden, New Jersey, United States of America and 70 other locations

Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....

Active, not recruiting
Advanced Ovarian Cancer
FIGO Stage III-IV
Drug: Olaparib 300mg tablets

Phase 3

AstraZeneca
AstraZeneca

Philadelphia, Pennsylvania, United States and 176 other locations

Phase 1 trial to study the safety, pharmacokinetic and Preliminary Efficacy of STRO-002 in combination with Bevacizumab.

Active, not recruiting
Ovary Cancer
Ovarian Carcinoma
Drug: STRO-002
Drug: Bevacizumab

Phase 1

Sutro Biopharma

Philadelphia, Pennsylvania, United States and 5 other locations

Phase 1 trial to study the safety, pharmacokinetics and preliminary efficacy of STRO-002 given intravenously every 3 weeks.

Active, not recruiting
Endometrial Cancer
Ovary Cancer
Drug: STRO-002

Phase 1

Sutro Biopharma

Philadelphia, Pennsylvania, United States and 26 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems